NCT00836706View on ClinicalTrials.gov

Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Healthy
Interventions
DRUG

clarithromycin

500 mg Tablet

DRUG

BIAXIN®

500 mg Tablet

Trial Locations (1)

56721

PRACS Institute, Ltd., East Grand Forks

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00836706 - Clarithromycin 500 mg Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter